Invention Grant
- Patent Title: Citrate salt of an indole derivative and its pharmaceutical use
- Patent Title (中): 吲哚衍生物的柠檬酸盐及其药物用途
-
Application No.: US12162540Application Date: 2007-01-31
-
Publication No.: US08008294B2Publication Date: 2011-08-30
- Inventor: Tesfai Sebhatu , Erica Ståhle
- Applicant: Tesfai Sebhatu , Erica Ståhle
- Applicant Address: SE Sodertalje
- Assignee: AstraZeneca AB
- Current Assignee: AstraZeneca AB
- Current Assignee Address: SE Sodertalje
- Agent Kenneth F. Mitchell
- International Application: PCT/SE2007/000086 WO 20070131
- International Announcement: WO2007/089191 WO 20070809
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; C07D413/14
Abstract:
The salt, the 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]1H-indole-5-carbonitrile citrate, a process for its preparation, pharmaceutical formulations containing it and the use of it in therapy, and particularly in the therapy of GSK3 related conditions and disorders.
Public/Granted literature
- US20090023732A1 Citrate Salt of an Indole Derivative and its Pharmaceutical Use Public/Granted day:2009-01-22
Information query
IPC分类:
